These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 53574)

  • 21. The effect of Corynebacterium parvum on T cell dependent tumor regression.
    McBride WH; Peters LJ; Mason KA; Barrow G
    J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms of antitumor action of Corynebacterium parvum: replicating short-lived T cells as the mediators of potentiated tumor-specific immunity.
    Tuttle RL; North RJ
    J Reticuloendothel Soc; 1976 Sep; 20(3):209-16. PubMed ID: 1086362
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the histamine sensitisation produced in mice by Corynebacterium parvum.
    Adlam C
    J Med Microbiol; 1973 Nov; 6(4):527-38. PubMed ID: 4357938
    [No Abstract]   [Full Text] [Related]  

  • 24. Mchanisms of antitumor action of Corynebacterium parvum: nonspecific tumor cell destruction at site of immunologically mediated sensitivity reaction to C. parvum.
    Tuttle RL; North RJ
    J Natl Cancer Inst; 1975 Dec; 55(6):1403-11. PubMed ID: 1206760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial with Corynebacterium parvum.
    Medenica R; Girard JP; Maurice P
    Dev Biol Stand; 1977 Apr 13-15; 38():483-5. PubMed ID: 344103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of killed Corynebacterium parvum suspensions in a murine mammary adenocarcinoma CaD2) system.
    Purnell DM; Otterstrom JR; Bartlett GL; Kreider JW
    J Natl Cancer Inst; 1976 Jun; 56(6):1171-5. PubMed ID: 994219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Corynebacterium parvum on tumor growth in the central nervous system of mice.
    Conley FK; Remington JS
    J Natl Cancer Inst; 1978 Sep; 61(3):827-32. PubMed ID: 278860
    [No Abstract]   [Full Text] [Related]  

  • 28. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corynebacterium parvum.
    Delmonte L; Oettgen HF; Hirshaut Y; Pinsky CM; Wanebo HJ
    Clin Bull; 1976; 6(1):31-4. PubMed ID: 1269143
    [No Abstract]   [Full Text] [Related]  

  • 30. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of intravenous infusion of Corynebacterium parvum on an immune profile of women with breast cancer.
    Webster DJ; Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():467-70. PubMed ID: 608540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corynebacterium parvum: a synonym for Propionibacterium acnes?
    Cummins CS; Johnson JL
    J Gen Microbiol; 1974 Feb; 80(2):433-42. PubMed ID: 4826546
    [No Abstract]   [Full Text] [Related]  

  • 33. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
    Ansell JD; Trail KN; McDougall CM; Inchley CJ
    J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings.
    Israël L; Edelstein R; Depierre A; Dimitrov N
    J Natl Cancer Inst; 1975 Jul; 55(1):29-33. PubMed ID: 1080521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of Corynebacterium parvum on the immune response in guinea pigs. I. Mode of enhancement of the anamnestic response and development of delayted hypersensitivity after treatment with Corynebacterium parvum].
    Halpern B; Gauthier-Rahman S; Besluau D
    C R Seances Soc Biol Fil; 1977; 171(6):1202-8. PubMed ID: 148948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Corynebacterium parvum and anaesthetics.
    Farquhar D; Loo TL; Reed R; Luna M
    Lancet; 1975 Apr; 1(7912):914. PubMed ID: 47551
    [No Abstract]   [Full Text] [Related]  

  • 37. Corynebacterium parvum as an immunotherapeutic anticancer agent.
    Scott MT
    Semin Oncol; 1974 Dec; 1(4):367-78. PubMed ID: 4620441
    [No Abstract]   [Full Text] [Related]  

  • 38. Organ distribution of Corynebacterium parvum labeled with iodine-125.
    Dimitrov NV; Greenberg CS; Denny T
    J Natl Cancer Inst; 1977 Feb; 58(2):287-94. PubMed ID: 833877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of intravenous Corynebacterium parvum on gut associated mononuclear phagocytes in normal and tumour bearing rats.
    Souter RG; Steer HW
    Clin Exp Immunol; 1982 Dec; 50(3):487-94. PubMed ID: 7165995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Damage caused by vaccine therapy and serotherapy].
    De Renzi S; Cave Bondi G
    Clin Ter; 1966 Sep; 38(6):497-500. PubMed ID: 5994648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.